This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
March 23–25, 2026
FIL (Feira Internacional de Lisboa), Lisbon, PortugalMarch 31 – April 1, 2026 | Digital Partnering

Victoria Gordon
CSO, Executive Director at QBiotics Group
Presenter

Profile

Victoria holds a PhD in Microbiology, Bachelor of Applied Science in Chemistry and Biology (Hons), Diplomas in Human and Animal Health, and is a Graduate of the Australian Institute of Company Directors. Victoria was elected a 2025 Fellow of the Australian Academy of Technological Sciences and Engineering (ATSE) for contributions to medical innovation. Victoria is Co-Founder and was CEO and Managing Director for 24 years of QBiotics Group the Australian small molecule drug discovery and development company. She is currently Chief Strategy Officer of QBiotics Group. Previous roles include Research Scientist for the Commonwealth and Industrial Research Organisation (CSIRO) and Manager of clonal production for Boral Timber Division. Victoria is an Executive Director of the QBiotics Group and its wholly-owned subsidiary companies, QBiotics Pty Ltd, EcoBiotics Pty Ltd, QBiotics Netherlands B.V. and QBiotics UK Limited. She is also a Non-Executive Director of the UK biotechnology investment fund Conviction Life Sciences Company.

Agenda Sessions

  • Oncology: QBiotics Group

    16:00